Coding Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 15

Coding Bio General Information

Description

Developer of a cell discovery platform designed to accelerate the development of new targets for chimeric antigen receptors. The company's platform uses artificial intelligence to design cell therapies through automation and computation, enabling patients to recover from illness with the help of curative therapeutics.

Contact Information

Website
www.coding.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gipsy Lane, Enterprise Centre
  • Oxford OX3 0BP
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Gipsy Lane, Enterprise Centre
  • Oxford OX3 0BP
  • England, United Kingdom

Coding Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coding Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 13-Feb-2026 Completed Generating Revenue
3. Seed Round 05-Sep-2023 Completed Generating Revenue
2. Seed Round 13-Apr-2022 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Coding Bio’s complete valuation and funding history, request access »

Coding Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2
Seed
Seed 659,485 $0.000127 $3.75 $3.75 1x $3.75 27.64%
To view Coding Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Coding Bio Patents

Coding Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202509058-D0 Method for the identification of t-cell engagers Pending 09-Jun-2025
EP-4805394-A1 Bcma binding molecules Pending 07-Nov-2023
GB-202317065-D0 Bcma binding molecules Inactive 07-Nov-2023
WO-2025099434-A1 Bcma binding molecules Inactive 07-Nov-2023
GB-202301949-D0 Cll1 and/or cd33 binding molecules Inactive 10-Feb-2023 C07K16/2803
To view Coding Bio’s complete patent history, request access »

Coding Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coding Bio Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bija Ventures Venture Capital Minority
Myeloma Investment Fund Not-For-Profit Venture Capital Minority
2048 Ventures Venture Capital Minority
Divergent Capital Impact Investing Minority
Divergent Capital (New York) Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Coding Bio FAQs

  • When was Coding Bio founded?

    Coding Bio was founded in 2020.

  • Where is Coding Bio headquartered?

    Coding Bio is headquartered in Oxford, United Kingdom.

  • What is the size of Coding Bio?

    Coding Bio has 19 total employees.

  • What industry is Coding Bio in?

    Coding Bio’s primary industry is Drug Discovery.

  • Is Coding Bio a private or public company?

    Coding Bio is a Private company.

  • What is Coding Bio’s current revenue?

    The current revenue for Coding Bio is .

  • How much funding has Coding Bio raised over time?

    Coding Bio has raised $3.62M.

  • Who are Coding Bio’s investors?

    Bija Ventures, Myeloma Investment Fund, 2048 Ventures, Divergent Capital, and Divergent Capital (New York) are 5 of 15 investors who have invested in Coding Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process